Cochlear Limited (CHEOF)
OTCMKTS · Delayed Price · Currency is USD
175.01
0.00 (0.00%)
At close: Dec 24, 2025
Cochlear Market Cap
Cochlear has a market cap or net worth of $11.5 billion as of December 26, 2025. Its market cap has decreased by -5.25% in one year.
Market Cap
11.50B
Enterprise Value
11.47B
Revenue
1.54B
Ranking
n/a
PE Ratio
45.09
Stock Price
$175.01
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 32.71M to 11.50B, an increase of 35,037.66%. That is a compound annual growth rate of 21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 11.50B | -2.07% |
| Dec 31, 2024 | 11.74B | -11.97% |
| Dec 29, 2023 | 13.33B | 46.11% |
| Dec 30, 2022 | 9.13B | -11.71% |
| Dec 31, 2021 | 10.34B | 7.83% |
| Dec 31, 2020 | 9.59B | 4.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 724.00M |
| Elite Pharmaceuticals | 520.52M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 376.54M |
| CytoDyn | 353.44M |
| Nika Pharmaceuticals | 291.10M |
| Silence Therapeutics | 290.02M |